Device Trial Radar · NCT04713774
Bone Density and Vascular Calcifications Evolution After Renal Transplant
Last checked: Nov 19, 2026Latest source record: Dec 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Sep 1, 2020
Primary completion
Dec 12, 2025
Study completion Dec 13, 2026
Sponsor
- Lead sponsor
- University of LiegeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 19, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
The investigators project is based on: * Assessment of bone architecture by high resolution peripheral scanner (HRpQCT) and bone densitometry (DEXA); * The non-invasive detection of vascular calcifications (by abdominal CT scanner) and bone abnormalities associated with kidney transplantation, as well as the analysis of evolution over time; * Longitudinal evaluation of nephrological clinical parameters (glomerular filtration rate, number and type of rejections, immunosuppressive medications) as well as biological and urinary parameters of mineral metabolism (parathormone, sclerostin, bone alkaline phosphatase) depending on the type and severity of bone abnormalities; * The evaluation of these nephrological clinical parameters and of the biological parameters of mineral metabolism depending on the extent and evolution of vascular calcifications but also on bone morphology; * The study of possible relationships between bone mass and muscle mass (and functioning)
Conditions
- Kidney Transplant; Complications
- Bone Loss
Interventions
High-resolution peripheral quantitative CT scanner (HRpQCT)Device
HR-pQCT images of the distal radius and distal tibia (non-dominant, non-fractured limb) will be obtained using the XtremeCT device with standard protocols. HR-pQCT images wil be analysed with standard software and extended cortical measures software. This software identifies the periosteal and endosteal boundaries, enabling assessment of cortical micro- structural bone properties, including apparent cortical thickness (Ct.Th, mm), cortical tissue mineral density (TMD, mgHA/cm3) and cortical porosity (Ct.Po, %).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bone density evolutionTime frame: At 1 year
- Bone density evolutionTime frame: At 2 year
- Bone micro-architecture evolutionTime frame: At 1 year
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centre Hospitalier Universitaire de Liège
Liège, Belgium · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.